Literature DB >> 30882169

Is Absence of Hydronephrosis a Risk Factor for Bleeding in Conventional Percutaneous Nephrolithotomy.

Hee Youn Kim1, Hyun-Sop Choe2, Dong Sup Lee2, Je Mo Yoo2, Seung-Ju Lee2.   

Abstract

PURPOSE: There is conflict of evidence regarding whether absence of hydronephrosis is a risk factor for bleeding in percutaneous nephrolithotomy (PNL). Moreover, among the stone complexity scoring system used for PNL (Guy's stone score, the S.T.O.N.E. nephrometry and the CROES nomogram), only the S.T.O.N.E. nephrometry score incorporates hydronephrosis as a risk factor. Therefore, this study aimed to compare perioperative outcomes according to the presence or absence of hydronephrosis in percutaneous nephrolithotomy (PCNL) patients and to investigate whether absence of hydronephrosis is a risk factor for blood transfusion rate.
MATERIALS AND METHODS: 281 patients who had undergone PCNL between December 2009 and April 2017 were divided according to the absence or presence of hydronephrosis (group I and group II, respectively). Perioperative outcomes were compared between the two groups. A multivariable regression analysis was performed to investigate whether hydronephrosis was a risk factor for blood transfusion rate.
RESULTS: Patients without hydronephrosis showed significantly longer operation time and admission period, lower stone-free rate and higher blood transfusion rate compared to patients with hydronephrosis (p < 0.05, p = 0.002, p = 0.011, and p < 0.05, respectively). Multivariate logistic regression analysis showed that hydronephrosis was a significant risk factor for blood transfusion (OR, 95% CI and p value was 0.353, 0.163-0.761 and 0.008, respectively).
CONCLUSION: Based on the results of the current study, we found that absence of hydronephrosis was a significant risk factor for blood transfusion in conventional PCNL.

Entities:  

Year:  2020        PMID: 30882169     DOI: 10.22037/uj.v0i0.4826

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  4 in total

1.  The safety and efficiency of a 1470 nm laser in obtaining tract hemostasis in tubeless percutaneous nephrolithotomy: a retrospective cross-sectional study.

Authors:  Huihui Zhang; Hanfeng Xu; Kuilin Fei; Dayong Guo; Youjun Duan
Journal:  BMC Urol       Date:  2022-07-02       Impact factor: 2.090

2.  Evaluating outcomes of complete supine percutaneous nephrolithotomy for staghorn vs multiple non-staghorn renal stones: a 10-year study.

Authors:  Reza Falahatkar; Tamkin Shahraki; Siavash Falahatkar; Samaneh Esmaeili; Parham Mashouf
Journal:  World J Urol       Date:  2021-01-05       Impact factor: 4.226

3.  No staghorn calculi and none/mild hydronephrosis may be risk factors for severe bleeding complications after percutaneous nephrolithotomy.

Authors:  Xue Dong; Dongnv Wang; Huangqi Zhang; Shuzong You; Wenting Pan; Peipei Pang; Chaoqian Chen; Hongjie Hu; Wenbin Ji
Journal:  BMC Urol       Date:  2021-08-13       Impact factor: 2.264

4.  Feasibility of contrast-enhanced ultrasound and flank position during percutaneous nephrolithotomy in patients with no apparent hydronephrosis: a randomized controlled trial.

Authors:  Zeng-Qin Liu; Jing Xie; Chu-Biao Zhao; Yan-Feng Liu; Zai-Shang Li; Ji-Nan Guo; Hong-Tao Jiang; Ke-Feng Xiao
Journal:  World J Urol       Date:  2022-01-21       Impact factor: 3.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.